← Leaderboards
Andre Der-Avakian
University Of California, San Diego
$4,419,757
Attributed
$7,121,916
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–22$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,121,916 · 5
By mechanism
R01$5,278,250 · 3
R44$1,688,500 · 1
F32$155,166 · 1
Top collaborators
- Victoria B Risbrough5 shared
- Nicholas David Cosford3 shared
- Daniel R Deaver3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Carrie R McDonald$13,638,302
- Jared William Young$14,211,149
- M G Finn$2,305,903
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseBaseNeurobiologyChronicMental DisordersBehavioralBehaviorRodentDesignEtiologyAnhedoniaSymptomsPharmaceutical PreparationsRewardsAnimalsDrug DiscoveryNeuronsCostPharmacotherapyLaboratoriesInnovationAnimal ModelClinically RelevantClinical Research
Grant awards (18)
Preclinical neurophysiological and behavioral assays of motivation and effort$391,694
R01 · FY2022 · MH · contact PI
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$725,450
R44 · FY2021 · DA
Preclinical neurophysiological and behavioral assays of motivation and effort$391,230
R01 · FY2021 · MH · contact PI
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies$249,579
R01 · FY2021 · AA
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$739,750
R44 · FY2020 · DA
Preclinical neurophysiological and behavioral assays of motivation and effort$390,013
R01 · FY2020 · MH · contact PI
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies$249,814
R01 · FY2020 · AA
PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications$223,300
R44 · FY2020 · DA
Preclinical neurophysiological and behavioral assays of motivation and effort$389,495
R01 · FY2019 · MH · contact PI
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies$249,877
R01 · FY2019 · AA
Lead optimization of Novel mGlu2 Negative Allosteric Modulators$785,204
R01 · FY2018 · MH
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies$249,939
R01 · FY2018 · AA
Lead optimization of Novel mGlu2 Negative Allosteric Modulators$785,204
R01 · FY2017 · MH
Developing rodent models of PTSD/AUD: leveraging clinic-based strategies$250,000
R01 · FY2017 · AA
Lead optimization of Novel mGlu2 Negative Allosteric Modulators$896,201
R01 · FY2016 · MH
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms$53,810
F32 · FY2010 · MH · contact PI
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms$51,710
F32 · FY2009 · MH · contact PI
A Translational Investigation of Anhedonia and its Underlying Neural Mechanisms$49,646
F32 · FY2008 · MH · contact PI